Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment
Dermatology · 2024
DOI: 10.1159/000535849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, 2024. Verfasst von Alessandro Borghi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Vulvar Lichen Sclerosus, Dyspareunia. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Vulvar lichen sclerosus (VLS) is characterized by progressive anatomical changes which become increasingly severe and irreversible. The objective of this study was to investigate if a “window of opportunity” exists in VLS, i.e., to assess if an early treatment may prevent disease progression and facilitate clearance of symptoms and/or signs.
Methods
This retrospective, cohort study included VLS patients treated for the first time with a topical corticosteroid, namely with mometasone furoate 0.1% ointment, for 12 weeks (2016–2021). Scoring of subjective symptoms (global subjective score, GSS, and dyspareunia) and clinical features (global objective score [GOS] and sclerosis-scarring-atrophy) was performed at baseline (T0) and at the control visit (T1). We assessed if the achievement of clearance in GSS, GOS, sclerosis-scarring-atrophy, or dyspareunia depended on the time elapsed between VLS onset and treatment initiation.
Results
Among the 168 patients (59.2 ± 13.2 years) included, the median time between VLS onset and first treatment was 14.0 months. At T1, 48.8% of patients achieved clearance of GSS, 28% of GOS and 11.9% of both GSS and GOS, 57.9% of dyspareunia, and 19.2% of sclerosis-scarring-atrophy. The logistic regression model showed that each 10-month increase in treatment initiation adversely affected the clearance of GSS while starting treatment within 6 months of disease onset was significantly associated with clearance of GOS and sclerosis-scarring-atrophy.
Conclusion
Early treatment is crucial in determining a complete healing of VLS-related symptoms and signs, especially of tissue sclerosis-scarring-atrophy, which appear poorly responsive, or even unresponsive, after the earliest stages of the disease. Thus our findings provide evidence for a “window of opportunity” in VLS treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
- Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy.
Zitieren
APA
Borghi, A., Flacco, M. E., Schettini, N., Toni, G., & Corazza, M. (2024). Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment. Dermatology. https://doi.org/10.1159/000535849
Vancouver
Borghi A, Flacco ME, Schettini N, Toni G, Corazza M. Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment. Dermatology. 2024. doi:10.1159/000535849
BibTeX
@article{Borghi2024,
author = {Borghi, Alessandro and Flacco, Maria Elena and Schettini, Natale and Toni, Giulia and Corazza, Monica},
title = {Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment},
journal = {Dermatology},
year = {2024},
doi = {10.1159/000535849}
}
EUVIMED